Skip to main content
Erschienen in: Clinical and Experimental Nephrology 3/2015

01.06.2015 | Original Article

Case series of thromboembolic complications in childhood nephrotic syndrome: Hacettepe experience

verfasst von: Betul Tavil, Fehime Kara, Rezan Topaloglu, Selin Aytac, Sule Unal, Baris Kuskonmaz, Mualla Cetin, Nesrin Besbas, Fatma Gumruk

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

The aim of this study was to describe the incidence and contributory risk factors for thromboembolic complications in children with nephrotic syndrome (NS) and thrombosis.

Methods

Among 188 children with the diagnosis of NS (80 girls; mean age: 12.6 ± 5.4 years) followed up in our hospital for the last 5 years, 17 (9.0 %) children (16 boys) identified as having thromboembolic complications. All 17 children with NS and thrombosis were screened for laboratory risk factors for thrombosis. The diagnosis was confirmed by cranial magnetic resonance imaging, doppler ultrasonography, and echocardiography.

Results

Among 17 children with thrombosis, 14 (82.3 %) were found to have focal segmental glomerulosclerosis (FSGS) as underlying pathology by renal biopsy. The mean age of the thrombotic children was 4.5 ± 3.2 years at the diagnosis of NS and that was 7.1 ± 4.9 years at the time of thrombosis. The mean time from NS diagnosis to the first thrombosis development was 2.6 ± 2.3 years. Thrombosis occurred during the first year of NS in 9/17 (52.9 %) children. Most of the children (88.2 %) had venous thrombosis. Among the screened risk factors, high factor VIII level (64.7 %) was the leading factor followed by decreased antithrombin III level (29.4 %). Furthermore, 4 children had central venous catheters and 2 had infection as clinical risk factors for thrombosis.

Conclusion

In this case series, subtype of FSGS, active disease state of NS, central venous catheters, and some inherited and acquired thrombotic risk factors have been identified as contributory factors for the development of thrombosis in children with NS.
Literatur
2.
Zurück zum Zitat Kerlin BA, Blatt NB, Fuh B, Zhao S, Lehman A, Blanchong C, et al. Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a midwest pediatric nephrology consortium (MWPNC) study. J Pediatr. 2009;155:105–10.PubMedCentralPubMedCrossRef Kerlin BA, Blatt NB, Fuh B, Zhao S, Lehman A, Blanchong C, et al. Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a midwest pediatric nephrology consortium (MWPNC) study. J Pediatr. 2009;155:105–10.PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol. 2012;7:513–20.PubMedCentralPubMedCrossRef Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol. 2012;7:513–20.PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Tizki S, Lasry F, Khalifa HH, Itri M. Primary focal segmental glomerular sclerosis in children: epidemiology and prognosis. Nephrol Ther. 2013;9:433–7.PubMedCrossRef Tizki S, Lasry F, Khalifa HH, Itri M. Primary focal segmental glomerular sclerosis in children: epidemiology and prognosis. Nephrol Ther. 2013;9:433–7.PubMedCrossRef
5.
Zurück zum Zitat Gokce M, Altan I, Unal S, Kuskonmaz B, Aytac S, Cetin M, et al. Recurrent pediatric thrombosis: the effect of underlying and/or coexisting factors. Blood Coagul Fibrinolysis. 2012;23:434–9.PubMedCrossRef Gokce M, Altan I, Unal S, Kuskonmaz B, Aytac S, Cetin M, et al. Recurrent pediatric thrombosis: the effect of underlying and/or coexisting factors. Blood Coagul Fibrinolysis. 2012;23:434–9.PubMedCrossRef
6.
Zurück zum Zitat Orkin SH, Nathan DG, Ginsburg D, Look AT, Fisher DE, Lux SE. Reference values in infancy and childhood. Nathan and Oski’s hematology of infancy and childhood. 7th ed. Philadelphia: Saunders, Elsevier; 2009. p. 1771–96. Orkin SH, Nathan DG, Ginsburg D, Look AT, Fisher DE, Lux SE. Reference values in infancy and childhood. Nathan and Oski’s hematology of infancy and childhood. 7th ed. Philadelphia: Saunders, Elsevier; 2009. p. 1771–96.
7.
Zurück zum Zitat Gürgey A, Mesci L. The prevalence of factor V Leiden (1691 G→A) mutation in Turkey. Turk J Pediatr. 1997;39:313–5.PubMed Gürgey A, Mesci L. The prevalence of factor V Leiden (1691 G→A) mutation in Turkey. Turk J Pediatr. 1997;39:313–5.PubMed
8.
Zurück zum Zitat Gürgey A, Hicsönmez G, Parlak H, Balta G, Celiker A. Prothrombin gene 20210 G-A mutation in Turkish patients with thrombosis. Am J Hematol. 1998;59:179–80.PubMedCrossRef Gürgey A, Hicsönmez G, Parlak H, Balta G, Celiker A. Prothrombin gene 20210 G-A mutation in Turkish patients with thrombosis. Am J Hematol. 1998;59:179–80.PubMedCrossRef
9.
Zurück zum Zitat Balta G, Gürgey A. Methylenetetrahydrofolate reductase (MTHFR) C677T mutation in Turkish patients with thrombosis. Turk J Pediatr. 1999;41:197–9.PubMed Balta G, Gürgey A. Methylenetetrahydrofolate reductase (MTHFR) C677T mutation in Turkish patients with thrombosis. Turk J Pediatr. 1999;41:197–9.PubMed
10.
Zurück zum Zitat Balta G, Altay C, Gurgey A. PAI-1 gene 4G/5G genotype: a risk factor for thrombosis in vessels of internal organs. Am J Hematol. 2002;71:89–93.PubMedCrossRef Balta G, Altay C, Gurgey A. PAI-1 gene 4G/5G genotype: a risk factor for thrombosis in vessels of internal organs. Am J Hematol. 2002;71:89–93.PubMedCrossRef
11.
Zurück zum Zitat Bilginer Y, Ozaltin F, Duzova A, Erdogan I, Aki TF, Demircin M, et al. Right atrial thrombosis complicating renal transplantation in a child. Pediatr Transplant. 2008;12:251–5.PubMedCrossRef Bilginer Y, Ozaltin F, Duzova A, Erdogan I, Aki TF, Demircin M, et al. Right atrial thrombosis complicating renal transplantation in a child. Pediatr Transplant. 2008;12:251–5.PubMedCrossRef
12.
Zurück zum Zitat Topaloğlu R, Saatçi U, Bakkaloğlu A, Beşbaş N, Başsoy Y. Evaluation of the hypercoagulable state by measuring protein C and antithrombin III levels in nephrotic syndrome and in familial mediterranean fever-related amyloidosis. Turk J Pediatr. 1992;34:15–20.PubMed Topaloğlu R, Saatçi U, Bakkaloğlu A, Beşbaş N, Başsoy Y. Evaluation of the hypercoagulable state by measuring protein C and antithrombin III levels in nephrotic syndrome and in familial mediterranean fever-related amyloidosis. Turk J Pediatr. 1992;34:15–20.PubMed
13.
14.
Zurück zum Zitat Rabelink TJ, Zwaginga JJ, Koomans HA, Sixma JJ. Thrombosis and hemostasis in renal disease. Kidney Int. 1994;46:287–96.PubMedCrossRef Rabelink TJ, Zwaginga JJ, Koomans HA, Sixma JJ. Thrombosis and hemostasis in renal disease. Kidney Int. 1994;46:287–96.PubMedCrossRef
15.
Zurück zum Zitat Abella EM. Hemostatic problems associated with renal disease. Int J Pediatr Hematol Oncol. 1994;1:43–51. Abella EM. Hemostatic problems associated with renal disease. Int J Pediatr Hematol Oncol. 1994;1:43–51.
16.
Zurück zum Zitat Hoyer PF, Gonda S, Barthels M, Krohn HP, Brodehl J. Thromboembolic complications in children with nephrotic syndrome. Acta Pediatr Scand. 1986;75:804–10.CrossRef Hoyer PF, Gonda S, Barthels M, Krohn HP, Brodehl J. Thromboembolic complications in children with nephrotic syndrome. Acta Pediatr Scand. 1986;75:804–10.CrossRef
17.
Zurück zum Zitat Lilova MI, Velkovski IG, Topalov IB. Thromboembolic complications in children with nephrotic syndrome in Bulgaria (1974—1996). Pediatr Nephrol. 2000;15:74–8.PubMedCrossRef Lilova MI, Velkovski IG, Topalov IB. Thromboembolic complications in children with nephrotic syndrome in Bulgaria (1974—1996). Pediatr Nephrol. 2000;15:74–8.PubMedCrossRef
18.
Zurück zum Zitat Zhang Q, Zeng C, Fu Y, Cheng Z, Zhang J, Liu Z. Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis. Nephrology (Carlton). 2012;17:338–45.CrossRef Zhang Q, Zeng C, Fu Y, Cheng Z, Zhang J, Liu Z. Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis. Nephrology (Carlton). 2012;17:338–45.CrossRef
19.
Zurück zum Zitat Tkaczyk M, Czupryniak A, Owczarek D, Lukamowicz J, Nowicki M. Markers of endothelial dysfunction in children with idiopathic nephrotic syndrome. Am J Nephrol. 2008;28:197–202.PubMedCrossRef Tkaczyk M, Czupryniak A, Owczarek D, Lukamowicz J, Nowicki M. Markers of endothelial dysfunction in children with idiopathic nephrotic syndrome. Am J Nephrol. 2008;28:197–202.PubMedCrossRef
20.
Zurück zum Zitat Gurgey A, Balta G, Gumruk F, Altay C. Analysis of some clinical and laboratory aspects of adolescent patients with thrombosis. Blood Coagul Fibrinolysis. 2004;15:657–62.PubMedCrossRef Gurgey A, Balta G, Gumruk F, Altay C. Analysis of some clinical and laboratory aspects of adolescent patients with thrombosis. Blood Coagul Fibrinolysis. 2004;15:657–62.PubMedCrossRef
21.
Zurück zum Zitat Boduroglu K, Alikasifoglu M, Anar B, Tuncbilek E. 677 →CT mutation on the methylenetetrahydrofolate reductase gene is not a risk factor for neural tube defects in Turkey. Arch Dis Child Fetal Neonatal Ed. 1998;78:F235.PubMedCrossRef Boduroglu K, Alikasifoglu M, Anar B, Tuncbilek E. 677 →CT mutation on the methylenetetrahydrofolate reductase gene is not a risk factor for neural tube defects in Turkey. Arch Dis Child Fetal Neonatal Ed. 1998;78:F235.PubMedCrossRef
22.
Zurück zum Zitat Akar N, Akar E, Deda G, Sipahi T, Orsal A. Factor V1691 G-A, prothrombin 20210 G-A, and methylenetetrahydrofolate reductase677 C-T variants in Turkish children with cerebral infarct. J Child Neurol. 1999;14:749–51.PubMedCrossRef Akar N, Akar E, Deda G, Sipahi T, Orsal A. Factor V1691 G-A, prothrombin 20210 G-A, and methylenetetrahydrofolate reductase677 C-T variants in Turkish children with cerebral infarct. J Child Neurol. 1999;14:749–51.PubMedCrossRef
23.
Zurück zum Zitat Balta G, Gürgey A. Methylenetetrahydrofolate reductase (MTHFR) C677T mutation in Turkish patients with thrombosis. Turk J Pediatr. 1999;41:197–9.PubMed Balta G, Gürgey A. Methylenetetrahydrofolate reductase (MTHFR) C677T mutation in Turkish patients with thrombosis. Turk J Pediatr. 1999;41:197–9.PubMed
24.
Zurück zum Zitat Boduroğlu K, Alanay Y, Alikaşifoğlu M, Aktaş D, Tunçbilek E. Analysis of MTHFR 1298A>C in addition to MTHFR 677C>T polymorphism as a risk factor for neural tube defects in the Turkish population. Turk J Pediatr. 2005;47:327–33.PubMed Boduroğlu K, Alanay Y, Alikaşifoğlu M, Aktaş D, Tunçbilek E. Analysis of MTHFR 1298A>C in addition to MTHFR 677C>T polymorphism as a risk factor for neural tube defects in the Turkish population. Turk J Pediatr. 2005;47:327–33.PubMed
25.
Zurück zum Zitat Manco-Johnson MJ. How i treat venous thrombosis in children. Blood. 2006;2006(107):21–9.CrossRef Manco-Johnson MJ. How i treat venous thrombosis in children. Blood. 2006;2006(107):21–9.CrossRef
Metadaten
Titel
Case series of thromboembolic complications in childhood nephrotic syndrome: Hacettepe experience
verfasst von
Betul Tavil
Fehime Kara
Rezan Topaloglu
Selin Aytac
Sule Unal
Baris Kuskonmaz
Mualla Cetin
Nesrin Besbas
Fatma Gumruk
Publikationsdatum
01.06.2015
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 3/2015
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-014-1005-y

Weitere Artikel der Ausgabe 3/2015

Clinical and Experimental Nephrology 3/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.